A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]

被引：0
|
作者：
Furqoni, Abdul Hadi [1 ,2 ]
Fajarwati, Indah [1 ]
Poetranto, Anna Lystia [1 ]
机构：
[1] Natl Res & Innovat Agcy BRIN, Cibinong Sci Ctr, Res Org Hlth, Ctr Biomed Res, Cibinong Bogor, West Java, Indonesia
[2] Natl Res & Innovat Agcy BRIN, Res Org Hlth, Ctr Biomed Res, Cibinong Sci Ctr, Jl Raya Bogor 490, Cibinong-Bogor Km 46, Cibinong Bogor 16911, West Java, Indonesia
来源：
PHARMACOGENOMICS & PERSONALIZED MEDICINE | 2023年 / 16卷
关键词：
D O I：
10.2147/PGPM.S442628
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：911 / 912
页数：2
相关论文
共 50 条
  • [1] A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant
    Tang, Qiong
    Gong, Dai
    Ye, Xiao-Min
    Xu, Jun-Ru
    Yang, Yi-Can
    Yan, Li-Juan
    Zou, Li
    Wen, Xiang-Lan
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2023, 16 : 817 - 823
  • [2] Long-term clinical course of adult-onset refractory epilepsy in cardiofaciocutaneous syndrome with a pathogenic MAP2K1 variant: a case report
    Tsuburaya-Suzuki, Rie
    Ohori, Sachiko
    Hamanaka, Kohei
    Fujita, Atsushi
    Matsumoto, Naomichi
    Kinoshita, Masako
    FRONTIERS IN GENETICS, 2024, 15
  • [3] Adult-onset epilepsy in cardiofaciocutaneous syndrome with MAP2K1 mutation
    Kinoshita, M.
    Ohori, S.
    Hamanaka, K.
    Fujita, A.
    Matsumoto, N.
    Tsuburaya-Suzuki, R.
    EPILEPSIA, 2023, 64 : 375 - 375
  • [4] A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib
    Kumamoto, Tadashi
    Aoki, Yuki
    Sonoda, Tomoko
    Yamanishi, Miho
    Arakawa, Ayumu
    Sugiyama, Masanaka
    Shirakawa, Nami
    Ishimaru, Sae
    Saito, Yoshimasa
    Maeshima, Akiko
    Maeda, Miho
    Ogawa, Chitose
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (02) : 228 - 232
  • [5] A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib
    Tadashi Kumamoto
    Yuki Aoki
    Tomoko Sonoda
    Miho Yamanishi
    Ayumu Arakawa
    Masanaka Sugiyama
    Nami Shirakawa
    Sae Ishimaru
    Yoshimasa Saito
    Akiko Maeshima
    Miho Maeda
    Chitose Ogawa
    International Journal of Hematology, 2019, 109 : 228 - 232
  • [6] Cardiofaciocutaneous Syndrome Phenotype in a Case with de novo KRAS Pathogenic Variant
    Sanri, Aslihan
    Gurkan, Hakan
    Demir, Selma
    MOLECULAR SYNDROMOLOGY, 2020, 10 (06) : 344 - 347
  • [7] Clinical and genetic features of a Noonan syndrome with a de novo MAP2K1 mutation: A case report
    Evelyn Diaz-Quiquia, Vasti
    Heredia, Paula
    Diaz-Reyes, Nelson
    Alarcon-Ruiz, Christoper A.
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2022, 15 (03):
  • [8] Detection of Pathogenic MAP2K1 Mutations in Hairy Cell Leukemia-Variant and Atypical Hairy Cell Leukemia
    Mason, E. F.
    Jai, Y.
    Garcia, E.
    Dal Cin, P.
    Pinkus, G. S.
    Lindeman, N. I.
    Sholl, L. M.
    Morgan, E. A.
    LABORATORY INVESTIGATION, 2014, 94 : 361A - 361A
  • [9] Detection of Pathogenic MAP2K1 Mutations in Hairy Cell Leukemia-Variant and Atypical Hairy Cell Leukemia
    Mason, E. F.
    Jai, Y.
    Garcia, E.
    Dal Cin, P.
    Pinkus, G. S.
    Lindeman, N. I.
    Sholl, L. M.
    Morgan, E. A.
    MODERN PATHOLOGY, 2014, 27 : 361A - 361A
  • [10] Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy
    Chen, Jing
    Che, Lin
    Xu, Chao
    Zhao, Suzhou
    Yang, Jiangfei
    Li, Mengting
    Li, Guimei
    Shen, Yiping
    GENE, 2020, 733
12345